Ironwood Pharmaceuticals (IRWD) Cash from Discontinued Operations (2010 - 2019)
Ironwood Pharmaceuticals (IRWD) reported Cash from Discontinued Operations of 11364000.0 for Q1 2019, up 191.53% sequentially from 3898000.0 in Q4 2018.
Ironwood Pharmaceuticals (IRWD) Cash from Discontinued Operations (2010 - 2019) Analysis & Trends
Ironwood Pharmaceuticals (IRWD) has 3 years of Cash from Discontinued Operations data on file, last reported at 11364000.0 in Q1 2019.
- For the quarter ending Q1 2019, Cash from Discontinued Operations changed N/A year-over-year to 11364000.0; the trailing twelve-month figure through Dec 2019 stood at 11364000.0 (up 281.73% YoY), and the FY2019 full-year result was 11364000.0, down 3.76% from the prior year.
- Cash from Discontinued Operations grew to 11364000.0 in Q1 2019, from 3898000.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 11364000.0 in Q1 2019 to a low of 2605000.0 in Q3 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.15 Bn | 87.28 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.52 Bn | 30.58 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.53 Bn | 23.47 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.21 Bn | 21.06 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.30 Bn | 18.50 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.42 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.59 Bn | 12.16 Bn | 785.00 Mn | - |
| 10 | Ironwood Pharmaceuticals | 638.28 Mn | 417.81 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 11.36 Mn |
| Mar 31, 2019 | 11.36 Mn |
| Dec 31, 2018 | 3.90 Mn |
| Dec 31, 2018 | 3.90 Mn |
| Sep 30, 2018 | 2.61 Mn |
| Sep 30, 2018 | 2.61 Mn |
| Sep 30, 2010 | -3.53 Mn |
| Sep 30, 2010 | -3.53 Mn |